FDA Approves First Cell Therapy for Type 1 Diabetes in the US
The first cellular therapy for type 1 diabetes, called Lantidra, was approved by the Food and Drug Administration (FDA) for use in the United States.
This is potentially good news for the 1.9 million people in the United States living with type 1 diabetes.
The FDA approved the drug on June 28, after two clinical trials in which 30 participants received between one and three doses of the medication.
The medication is approved for adults with type 1 diabetes, facing repeated episodes of severely low blood sugar, despite intense diabetes management and careful lifestyle.
New Diabetes Drug Uses Pancreatic Cells From Cadavers
Lantidra is the first treatment approved for people living with the disorder, who are normally unable to regulate their blood sugar levels using standard insulin shots or infusions….